The mevalonic acid (MVA) and methylerythritol phosphate (MEP) pathways for isoprenoid biosynthesis both culminate in the production of the two-five carbon prenyl diphosphates: dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP). These are the building blocks for higher isoprenoids, including many that have industrial and pharmaceutical applications. With growing interest in producing commercial isoprenoids through microbial engineering, reports have appeared of toxicity associated with the accumulation of prenyl diphosphates in Escherichia coli expressing a heterologous MVA pathway. Here we explored whether similar prenyl diphosphate toxicity, related to MEP pathway flux, could also be observed in the bacterium Bacillus subtilis. After genetic and metabolic manipulations of the endogenous MEP pathway in B. subtilis, measurements of cell growth, MEP pathway flux, and DMAPP contents suggested cytotoxicity related to prenyl diphosphate accumulation. These results have implications as to understanding the factors impacting isoprenoid biosynthesis in microbial systems. Key words: cytotoxicity; isoprene; prenyl diphosphate; methylerythritol phosphate pathway Isoprenoids are one of the most diverse and abundant groups of secondary metabolites produced in biological systems; their numbers are estimated at over 50,000 species. 1) The majority are biosynthesized in plants, where they are necessary for electron transport, membrane fluidity, light harvesting, photoprotection, and membrane anchoring of biomolecules. 2) They have also been identified as important modulators of plant-plant and plant-insect interactions. 3) In bacteria, isoprenoids function as essential metabolites including the dolichols; the side chains of menaquinones, ubiquinones and some modified tRNAs; and quorum-sensing molecules. [4] [5] [6] Isoprenoids are formed through two distinct biochemical pathways: the recently discovered methylerythritol phosphate (MEP) pathway and the classical mevalonic acid (MVA) pathway. The MEP pathway starts with the condensation of one molecule of pyruvate with one molecule of glyceraldehyde-3-phosphate ( Fig. 1 ). It is found in plant plastids, some eubacteria, algae, and the malaria parasite. The MVA pathway utilizes three molecules of acetyl CoA and is found in plant cytoplasms, animals, some eubacteria, and archaea. 1) Despite these differences, both pathways produce the five carbon molecules isopentenyl diphosphate (IPP) and its allylic isomer dimethylallyl diphosphate (DMAPP). IPP and DMAPP are interconverted by an IPP isomerase, which is essential in cells containing the MVA pathway, but not in those with the MEP pathway, as a branch point provides for the independent synthesis of both. 7) The taxonomic distribution of the two pathways, as well as that of Type I and Type II IPP isomerases, has proven difficult to determine among bacteria, 8) but in all organisms, higher isoprenoids are made from variations on the C5 metabolic building blocks, with DMAPP acting as the primer to which one or multiple IPP molecules are added.
The isoprenoid pathways receive a great deal of attention due to pharmaceutical applications. The MEP pathway has potential as an antimicrobial target since it is found in many pathogenic microorganisms, though not in humans. 9) Further, several plant-produced isoprenoids have been studied for their uses as medication, including the chemotherapeutic Taxol and the antimalarial agent arteminisn. 10) The commercial use of isoprenoids such as these has proven problematic, however, since they are commonly difficult to extract from their plant sources in significant quantities and/or their syntheses are complicated and costly. 11) Hence, microbial production of many isoprenoid compounds has significant commercial potential.
In engineering the bacterial powerhouse E. coli to produce various higher isoprenoids, several issues have been encountered. First, because of obviously inherent controls over the endogenous MEP pathway, the carbon flux to the non-natural compounds has remained low. Attempts to overcome pathway regulation by increasing the levels of key pathway enzymes have been somewhat successful, but isoprenoids are not yet produced at levels that allow for this approach to be used in pharmaceutical applications. 11) In order to bypass endogenous controls over the MEP pathway, an entire heterologous MVA pathway was expressed in E. coli cells, but when the carbon flux through the exogenous pathway was increased, potent precursor level-dependent cytotoxicity was observed. 10) However, cells grew normally when y To whom correspondence should be addressed. Tel: +1-989-964-2197; E-mail: tsivy@svsu.edu Abbreviations: DMAPP, dimethylallyl diphosphate; DOX(P), deoxyxylulose (phosphate); GC-RGD, gas chromatography-reduction gas detection; IPP, isopentenyl diphosphate; MBO, methylbutenols; MEP, methylerythritol phosphate; MVA, mevalonic acid they were engineered to synthesize added higher isoprenoids, consuming the pools of IPP and DMAPP. Hence, this effect has been deemed an IPP toxicity. 10) Since cellular housekeeping, cells ridding themselves of unwanted or toxic metabolites, is being detected with increasing frequency, 12) we wanted to expand on this research to determine whether similar IPP toxicity exists in the gram-positive model system Bacillus subtilis. While both E. coli and B. subtilis rely on the MEP pathway for isoprenoid biosynthesis, B. subtilis shows measured levels of DMAPP that are two orders of magnitude greater than E. coli, 13) suggesting higher endogenous pathway activity and the possibility of reduced cellular sensitivity to increased IPP and DMAPP concentrations. In addition, unlike E. coli, B. subtilis emits the volatile hemiterpene isoprene (2-methyl-1,3-butadiene) from enzymatic catalysis of DMAPP, providing a novel reporter system for flux though the MEP pathway. 14) Thus B. subtilis was utilized as a model experimental system to study the biochemical basis of IPP toxicity due to an endogenous pathway, rather than an overexpressed heterologous pathway when the isoprenoid-related death was previ-ously detected. 10) Here we report how alteration of the levels of IPP and DMAPP with genetic and metabolic MEP pathway manipulations in B. subtilis impacted cellular growth rates and isoprene production, in such a way as to suggest a similar cytotoxicity in this system.
Materials and Methods
Bacterial strains and growth. E. coli was routinely grown on Luria-Bertania (LB) agar plates with appropriate antibiotics, and B. subtilis was routinely grown on Tryptose Blood Agar Base (TBAB) plates with appropriate antibiotics. In some experiments, cells were grown in LB broth or a defined minimal medium (HGG), which contained (per liter) 5 g of glycerol, 5 g of monosodium glutamate, 4.4 g of K 2 HPO 4 , 
Preparation of B. subtilis IPP isomerase (ypgA) null mutant:
Construction of spectinomycin cassette with ypgA flanking regions. A two-step PCR method of creating long homologous regions flanking a spectinomycin cassette was followed as described by Wach. 15) In the first PCR reaction, two long flanking primers were created by amplifying 1-kb regions at the 5 0 and 3 0 ends of the ypgA gene with Shown are the pathway manipulations described in the text: the position of the ypgA gene product, the inhibition point by fosmidomycin, and the addition of DOX and methylbutenols.
Taq polymerase (Promega, Madison, WI). The oligonucleotides used in priming the 5 0 region were y1 (5 0 -GACTTTGGCGCGTTTCTTGA-TATTGG-3 0 ) and y2 (5 0 -ACATGTATTCACGAACGAAAATCGAC-AGTGCGTTTGCTCCAATCATCT'C-3 0 ), and the oligonucleotides used in priming the 3 0 region were y3 (5 0 -ATTTTAGAAAACAA-TAAACCCTTGCAACATCAAGCTATAGTGTGCGATAAAT-3 0 ) and y4 (5 0 -ACCAGCCGCTATCAACCCCAGT-3 0 ) (Invitrogen, Carlsbad, CA). The template was wild-type B. subtilis 6051 genomic DNA, prepared by the method of Cutting and Vander Horn. 16) The PCR program consisted of 25 cycles of 1 min at 95 C, 1 min at 50 C, and 2 min at 72 C. The underlined bases of y2 and y3 became the 5 0 and 3 0 ends of L1 and L2 and overlapped with ends of the spectinomycin gene contained in pDG1726. One-tenth mg of L1 and L2 were primers for PCR2. The template was 0.2 mg of pDG1726 that had been purified from E. coli RL1193 with a plasmid purification kit (Qiagen, Valencia, CA), linearized with HindIII (Promega), and further purified with a Qiagen gel purification kit. PCR2 was done with buffer 3 and the Taq polymerase provided in the Expand Long Template PCR system (Roche, Penzberg, Germany). The PCR program consisted of 2 min at 94 C; 10 cycles of 30 s at 94 C, 30 s at 60 C, and 6 min at 72 C; 20 cycles of 30 s at 94 C, 30 s at 60 C, and a 6 min + 20 s increase per cycle at 72 C; and 10 min at 72 C. The product was 3.1-kb, as each long primer was 1-kb and the spectinomycin gene was 1.1-kb. The conditions for PCR3 were exactly the same as for PCR2, except that 1 mL of PCR2 template and 0.4 mM y1 and y4 primers were used to further amplify the new construct.
Transformation of B. subtilis JH642. The construct was used to transform B. subtilis JH642 following the method of Anagnostopolus and Spizizen. 17) Briefly, B. subtilis JH642 was grown overnight on TBAB medium. A single colony was transferred to 2.5 mL of MG medium as described, 17) but supplemented with 50 mg/mL Trp and Phe, and was grown for 4 h with shaking at 37 C. After centrifugation, cells were resuspended in 1 mL fresh MG medium supplemented with 5 mM MgSO 4 . The culture was shaken for 90 min at 37 C with the addition of 10 mL of PCR3 DNA and then plated on TBAB plates with 100 mg mL À1 spectinomycin to select for transformants. Resulting colonies were tested for the presence of the spectinomycin cassette by PCR with primers y1 and y4; the spectinomycin gene is 0.5-kb longer than the wild-type ypgA gene. The null strain was named JH-ypgA.
Transduction of mutant DNA into B. subtilis 6051. SPP1 phages were prepared and used to transduce the mutant DNA from B. subtilis JH-ypgA into the wild-type B. subtilis 6051 as described previously. 18) Briefly, phages were prepared by infecting donor JH-ypgA cells and harvesting resulting lysates. After incubation of the recipient 6051 cells with the phage-containing lysate, cells were plated on TBAB + 100 mg mL À1 spectinomycin. Colonies were tested to identify transformants by PCR with primers y1 and y4.
Preparation of B. subtilis with constitutively transcribed ypgA. Plasmid pBCJ164.3 was prepared from overnight liquid cultures of E. coli ECE176 with a Qiagen plasmid prep kit. pBCJ164.3 carries the genes for ampicillin and chloramphenicol resistance as well as the promoter and terminator regions of the B. subtilis rpsD gene joined by an Nde1 site. B. subtilis 6051 genomic DNA was used as a template for PCR with oligonucleotides yF (5 0 -GGGCATATGGTGACTCGAG-CAGAACGAAA-3 0 ) and yR (5 0 -GGGCATATGTCGCACACTA-TAGCTTGA-3 0 ). The product of this reaction was the full-length ypgA gene (the start codon is shown in bold in the yF sequence above) with length of 1.1-kb. pBCJ164.3 and the PCR product were enzymatically cleaved with Ndel, whose recognition sequence was added as overhangs to the PCR product and is underlined in the yF and yR sequences above. After purification with a Qiagen gel extraction kit, the plasmid and insert were ligated with a Rapid DNA Ligation Kit (Roche, Mannheim, Germany). The new plasmid, called pBJypgA, was used to transform E. coli DH5. Transformants were selected for with 100 mg mL À1 ampicillin. Plasmid was prepped with a Qiagen plasmid kit from positive clones. B. subtilis JHÀypgA was transformed as described above with pBJypgA to produce strain JHþypgA. DNA from this strain was packaged into SPP1 phages, transduced into B. subtilis TS1, and plated on TBAB with 100 mg mL À1 spectinomycin and 5 mg mL À1 chloramphenicol. The resulting strain, B. subtilis TS2, had the natural ypgA gene knocked out and an integrated ypgA gene following a constitutively active promoter.
Measurements of isoprene and DMAPP. B. subtilis strains were grown to high density overnight in LB broth with shaking at 37 C. Typically one-tenth of final culture volume was inoculated into fresh medium. For assays to determine isoprene production, total culture volume was 1 mL in a 30-mL septa-lined screw-capped glass vial. Two mL of headspace was removed with an air-tight syringe after a determined time and injected onto a GC-RGD2 instrument similar to the one described in Greenberg et al. 19) This instrument runs at 100 C with a He flow rate of 28 cc min À1 , is equipped with a column made of Unibeads 3S 60/80 (Alltech Associates, Deerfield, IL), and is coupled to a RGD2 reduction gas detector (Trace Analytical, Menlo Park, CA). Isoprene production was calculated by converting GC peak area units to pmol isoprene by a calibration performed with an isoprene gas standard (Scott Specialty Gases, Longmont, CO.) DMAPP levels were determined by the method of Fisher et al. 13 ) with a total of 50 mL of bacterial culture harvested at the determined time for analysis. After centrifugation to pellet cells, the spent medium was discarded and the cells resuspended in water. This cell sample was incubated with 4 M H 2 SO 4 for 30 min at 30 C in a 4.8-mL screwcapped, septa-lined vial. Two mL of headspace was removed with an air-tight syringe and analyzed for isoprene levels by injection onto the GC-RGD2. DMAPP amounts were determined by comparison of isoprene in the headspace of samples to a standard curve generated by measuring the amount of isoprene produced by acidification of DMAPP standards. DMAPP was synthesized by the method of Keller and Thompson. 20) RT-PCR. Total RNA was prepped from 5 mL bacterial cultures grown to an OD600 of 5 using an RNeasy Mini Kit (Qiagen). A 20-mL reverse transcription reaction followed by quantitative polymerase chain reaction was done with 100 ng of RNA template in 1 mL of RNase-free H 2 O, 10 mL 2x Sybr Green, and 0.2 mL RT-PCR mix, all included in the Quantitect SYBR RT-PCR kit (Qiagen), using the LightCycler 2.0 (Roche) with data analysis by LightCycler Software 4 (Roche). The oligonucleotides for priming the PCR reaction were from Proligo (Boulder, CO) and were as follows: yRTf (5 0 -ATGATTGG-AGCAAACGCACTGCAGA-3 0 ) and yRTr (5 0 -CTTTCCTGCTGATG-CTTTGCTCATA-3 0 ) for ypgA; dRTf (5 0 -AGCCCGAAAGACAAA-TTTTTATGGG-3 0 ) and dRTr (5 0 -CCAAACATCGTGCTCGCTTT-CAC-3 0 ) for dxs; pRTf (5 0 GCGGATGATGATTATTTTGATGAGA-TGG-3 0 ) and pRTr (5 0 -GGCAGGCCGCCGTCAGCGAA-3 0 ) for phoB.
Minimum inhibitory concentration (MIC) determination for fosmidomycin. Ten mL of stationary phase B. subtilis was added to 90 mL of fresh minimal medium containing varying concentrations of fosmidomycin (Invitrogen, Carlsbad, CA). The cultures were grown in triplicate in 96-well plates for 24 h at 37 C. The MIC was assigned as the amount of fosmidomycin needed for all three cultures to fail to reach an OD600 of 0.1.
Growth of cells with deoxyxylulose. DOX was synthesized by the method of Keller. 21) Overnight cultures of B. subtilis in HGG broth were diluted 10-fold into new medium and grown with specified amounts of DOX in 30-mL septa-lined screw-cap vials. At the end of 4 h, the isoprene in the headspace was measured as above and the OD600 of the cells was determined.
Results

Deletion of B. subtilis Type II IPP isomerase
In an attempt to alter the levels of the prenyl diphosphates of B. subtilis, we created a ypgA null mutant (TS1). The ypgA gene codes for Type II IPP isomerase and is the only non-essential gene in the MEP pathway in B. subtilis. 22) A DNA construct was made that positioned the spectinomycin resistance gene between the long non-coding regions flanking the ypgA gene. Because the wild-type 6051 strain in which we do our studies does not readily take up DNA, laboratory strain B. subtilis JH642 was initially transformed with the construct. After a double recombination event that positioned the spectinomycin resistance gene in place of ypgA in the genome, the DNA from the resulting strain was packaged into SPP1 phages and transduced into B. subtilis 6051, creating strain TS1. In order to be able to attribute any changes in MEP pathway function or in growth specifically to changes in IPP isomerase activity, TS1 was then complemented with a constitutively transcribed ypgA gene. To do this, the ypgA gene was inserted behind the rpsD promoter in strain TS1, creating strain TS2. The RT-PCR results in Fig. 2A show lack of expression of a ypgA gene in TS1 and restoration of transcription in TS2. That the levels of ypgA gene transcription were higher in TS2 than those of wild-type 6051 most likely reflects the constitutive activity of the rpsD promoter. As the figure also indicates, the transcription of dxs, which codes for DOXP synthase, the first enzyme of the MEP pathway (see Fig. 1 ), was not affected by the lack of an IPP isomerase gene. Measurements were done at midlogarithmic growth, as this has been found to be when transcription of ypgA is highest 23) and when isoprene production is most marked. 14) For consistency, all subsequent experiments had variables measured at the same point in growth.
As shown in Fig. 2B , the levels of DMAPP increased significantly (56%) in the strain lacking an IPP isomerase (TS1) when compared to the strains expressing an IPP isomerase (6051 and TS2). Since isoprene production has been found to be highly dependent on DMAPP levels in previous experiments on both plants and bacteria, 24, 25) measurements of this metabolite can be used to ascertain changes in flux through the MEP pathway. As expected, the production of isoprene mirrored the differences in DMAPP levels, as depicted in Fig. 2C (39%, p ¼ 0:0009).
Of special interest are the differences in growth of the knockout strain versus those with a functional IPP isomerase, as strain TS1 grows significantly better than 6051 and TS2 (Fig. 2D ).
Use of fosmidomycin to decrease carbon flux through the MEP pathway of B. subtilis
Fosmidomycin is a well-characterized competitive inhibitor of DOXP reductoisomerase (see Fig. 1 ). 26) The minimum inhibitory concentration of wild-type B. subtilis 6051 was determined to be 8 mM, thus, a level of 1 mM inhibitor was chosen for our experiments in order not to adversely affect cell growth, while decreasing the activity of DOXP reductoisomerase. This should limit carbon flow through the pathway and make Variables in the 3 B. subtilis strains, wild-type 6051, TS1, and TS2, were measured as described in ''Materials and Methods'' in cells grown to mid-logarithmic phase in LB medium. A, RT-PCR of ypgA and dxs. Total RNA from cells was reverse transcribed and subjected to qPCR with the primers for the ypgA, dxs, and phoB genes. Levels were normalized to that of a housekeeping gene, phoB. Then the amount of transcript in 6051 was set to 1, with that of the other two strains set accordingly. Data are the average of nine RT-PCR experiments from three separate RNA preparations. B, DMAPP levels were determined by acidification of cell samples (n ¼ 5). C, Isoprene produced by cells as determined by GC-RGD (n ¼ 3). D, Cell growth as measured by optical density at 600 nm (n ¼ 5). Measurements shown in B and C were normalized to the OD600 of the cell samples. All results are mean AE SD. Statistics were calculated by ANOVA followed by Tukey HSD analysis. Differences at p < 0:05 are indicated by different letters above bars. it possible to measure any impact on DMAPP levels, isoprene emission, and cell density without inhibiting cell growth exclusively due to fosmidomyin. As expected, DMAPP levels decreased by 92% ( Fig. 3A) and isoprene production exhibited a concomitant decrease of 62% (Fig. 3B ) in cells treated with fosmidomycin. Cell growth increased significantly (p ¼ 0:01) in the fosmidomycin-treated cells (Fig. 3C ).
Addition of carbon skeletons to the MEP pathway of B. subtilis
To increase the amount of carbon in the MEP pathway, two approaches were used. First, B. subtilis 6051 cells were fed deoxyxylulose (DOX), the nonphosphorylated, cell-permeable analog of deoxyxylulose phosphate, the first intermediate in the MEP pathway (see Fig. 1 ). In silico studies have indicated the presence of a putative DOX kinase in B. subtilis with high sequence similarity to an E. coli enzyme, 27) suggesting that B. subtilis has the capability to convert DOX to DOXP in vivo, potentially increasing flux through the MEP pathway. As seen in Fig. 4A, 1 mM DOX had no effect on isoprene emissions, while 10 mM DOX increased isoprene production 36% in comparison to non-treated cells. The production of isoprene decreased significantly in cells treated with 50 mM DOX. As Fig. 4B indicates, the crash in isoprene production was due to the lack of cell growth at the higher levels of DOX. Growth was not restored when cells were transferred to fresh media without DOX. Increasing levels of xylulose did not impact isoprene production or cell growth in any experiments, which is indicative of DOX-specific and not C5 carbohydrate-general effects. Due to limited amounts of DOX, we were unable to obtain a sufficient number of treated cells to measure cellular DMAPP contents, and hence relied on isoprene as an indicator of pathway flux.
An alternative method of enhancing MEP pathway flux might be to feed cells permeable carbon skeletons in the form of prenyl alcohol. 3-methyl-3-buten-1-ol (331-MBO) and 3-methyl-2-buten-1-ol (321-MBO) are the alcohol analogs of IPP and DMAPP respectively. Previous studies have found that when MBOs are added to the growth medium of a Synechocystis strain with normally fatal mutations in the MEP pathway, the cells survive, presumably by converting prenyl alcohols to IPP and DMAPP for use in production of essential higher isoprenoids. 28) It has not been reported whether B. subtilis is capable of using MBOs as intermediates in the MEP pathway, but as shown in Fig. 5 , growth was sensitive to increasing levels of 331-MBO and 321-MBO, but remained unaffected by increasing concentrations of 2-methyl-3-buten-2-ol (232-MBO), another biologically relevant molecule that is produced enzymatically from DMAPP by some pine trees. 29 ) Thus it appears that the toxicity is due to the IPP and DMAPP MBO analogs and not to another C5 prenyl alcohol, with 331-MBO (the IPP analog) having a more pronounced effect on cell viability.
Discussion
In view of the fact that a pronounced IPP toxicity was recently reported in engineered E. coli overexpressing an exogenous mevalonic acid pathway, 10) we set out to determine whether the endogenous MEP pathway of B. subtilis, which also produces IPP, shows similar evidence of cytotoxicity with increasing pathway flux. B. subtilis was chosen for these studies for several reasons. First, the intracellular concentration of DMAPP, the allylic isomer of IPP, is 100-500 times greater in B. subtilis than in E. coli, suggesting B. subtilis has a reduced sensitivity to the cytotoxic effects of prenyl diphosphates. Additionally, because toxicity was originally observed during overexpression of a nonnatural MVA pathway, we set out to determine whether such toxicity might be associated with an endogenous MEP pathway. Finally, because B. subtilis enzymatically produces the quantifiable metabolite isoprene from DMAPP, it can serve as a useful endogenous reporter of MEP pathway flux.
Initially we conducted studies with a B. subtilis IPP isomerase mutant and a rescue strain. Type I IPP isomerase (found in E. coli) has been implicated as a control point in the moderation of carbon flow through the MEP pathway in both plants and bacteria. 9, 30) We expected that if this were the case for the Type II enzyme in B. subtilis, the DMAPP concentration, and subsequently isoprene production and perhaps growth, would be altered. Our results confirm the role of prenyl diphosphates in influencing cell growth in B. subtilis. While current analytical methods make it difficult to measure IPP specifically, the increase in DMAPP pools in the cells lacking an IPP isomerase corresponds with a significant amplification of growth. Additionally, the knockout provides evidence that isoprene production closely tracks changes in DMAPP levels. While Julsing et al. did not detect a change in isoprene emission in the B. subtilis 168 IPP isomerase mutant, 31) this strain produces substantially less isoprene than the 6051 strain used here, making differences in underlying rates of biosynthesis difficult to measure.
Not only are the results presented here applicable to the cytotoxicity questions, they also suggest striking differences between the Type I IPP isomerase, of which there have been extensive studies, and the Type II isomerase, of which studies have been limited primarily to recombinant enzymes. Our results confirm previous reports as to the non-essentiality of an IPP isomerase in B. subtilis, 23) since cells grew well on minimal medium with and without a functional IPP isomerase. However, this is the first study that indicates an in vivo function for the Type II IPP isomerase in B. subtilis. E. coli, which contains the MEP pathway, has a Type I isomerase that appears to function as a salvage enzyme, adjusting the intracellular concentrations of IPP and DMAPP. 30) The E. coli MEP pathway branch enzyme, the IspH protein, produces IPP and DMAPP in a 5:1 ratio in vitro. 32 been proposed that the isomerase favors the production of DMAPP, adjusting this ratio to physiologically more relevant levels. 33) However, our results indicate that the B. subtilis isomerase favors IPP in the equilibrium between IPP and DMAPP in vivo, as DMAPP levels are higher in cells lacking the enzyme. Perhaps the two types of enzymes adjust the equilibrium concentrations of IPP and DMAPP in opposite manners. The 670 mm Km for IPP of the B. subtilis Type II enzyme is 100-fold higher than that of the E. coli Type I isomerase, 34) confirming that there are inherent differences in functions of the two enzymes. Clearly, additional work on the enzymology of Type I and Type II IPP isomerases is warranted.
Experiments that more explicitly manipulate the carbon flux through the MEP pathway also confirm a toxic effect of pathway intermediates in B. subtilis. When an essential MEP pathway enzyme was inhibited by fosmidomycin, the cells grew significantly better. This was probably the result of both DMAPP and IPP being decreased in such a way as yet to support essential higher isoprenoid biosynthesis fully, but to well below the levels that induce cell death.
Conversely, when carbon was added to the pathway in the form of cell-permeable analogs of DOXP and IPP/ DMAPP, DOX and MBOs respectively, clear evidence of cytotoxicity was observed. While we were not able to measure DMAPP and IPP in the DOX-fed cells, we hypothesize that both showed increased cellular concentrations. The excess DMAPP can be converted to isoprene up to intermediate levels of DOX treatment, perhaps to saturation of the isoprene synthase enzyme, but the concurrent increase in IPP precludes an effect on cell viability. At high levels of DOX treatment, isoprene synthase is unable to convert all of the excess DMAPP to isoprene. The result is that the two prenyl diphosphates presumably reach toxic concentrations.
Martin et al., were not able to separate IPP and DMAPP to pinpoint whether either metabolite is specifically responsible for the suggested IPP toxicity in MVA pathway-engineered E. coli cells, but they did detect cell death with increased levels of farnesyl diphosphate, the C15 isoprenoid, which suggests that prenyl diphosphates in general cause some cytotoxicity in E. coli. 10) Our results indicate that this might also be the case for B. subtilis, and point to IPP having a more detrimental effect on cell growth than DMAPP, as the cells without an IPP isomerase, and as a result higher levels of DMAPP and presumably lower levels of IPP, grew to higher densities. B. subtilis cells consistently exhibited greater diminished growth when grown with the IPP MBO analog in comparison to the DMAPP MBO analog. Results were similar when MBOs were added to B. subtilis TS1, which lacks an IPP isomerase (data not shown), and thus the ability to interconvert between IPP and DMAPP. This provides further evidence that IPP is more toxic. Unfortunately, it could not be determined whether the MBOs were converted to prenyl diphosphates, as the prenyl alcohols and diphosphates could not be differentiated by our analytical methods. Consistent with previous studies in E. coli, our results do strongly suggest that increased cytotoxicity is probably related, at the very least, to the basic carbon backbone of the prenyl diphosphates.
It is of interest that Withers et al. have isolated genes from a B. subtilis library, nudF and yhfR. The enzymes encoded by each produce 331-MBO from DMAPP and are capable of relieving the toxicity of the high-flux heterologous MVA pathway in E. coli. 35) Perhaps the production and release of compounds such as isoprene and methylbutenols in B. subtilis has evolved as a mechanism to avoid the cell death associated with high levels of prenyl diphosphates. In this way, the function of isoprene emission itself in B. subtilis might be that of a safety valve metabolite, and the strong dependence of its production on DMAPP content substantiates this possibility. It should be noted, then, that the IPP molecule might not actually be more toxic than the DMAPP molecule, but that the cell is better able to rid itself of DMAPP through its conversion to isoprene, making its toxicity less evident. In view of the fact that much work has gone into finding the gene that specifically codes for an isoprene synthase of B. subtilis in our laboratories and others so far without success, such an enzyme for the sole purpose of isoprene production might not exist, and isoprene might, in fact, be a by-product of a reaction such as those of the nudF or yhfR gene products, both of which consume DMAPP. Efforts to confirm or disconfirm this possibility are underway.
Application of exogenous DOX has also been found to influence MEP pathway dynamics in other systems. Similarly to our results for B. subtilis, isoprene emission increased significantly in eucalyptus leaves when they were fed exogenous DOX, but at the highest levels of DOX there was a measurable decrease in photosynthesis, 36) suggesting that IPP toxicity, or a form of toxicity related to MEP pathway flux, is present in more than just microbial systems. The authors of that study attribute the observed decrease in photosynthesis to phosphate sequestration due to increased flux through the MEP pathway leading to the formation of more prenyl diphosphates, 36) although they did not specifically test this. Phosphate sequestration also seemed a reasonable explanation for the cytotoxicity we observed in B. subtilis. In order to explore this possibility, cells were grown with varying levels of inorganic phosphate and methylbutenols. If phosphorylation of MBOs results in phosphate sequestration, cytotoxicity should be more evident at lower levels of P i , but this was not observed (data not shown). Further, treatment of cells with MBOs did not change transcription, measured by RT-PCR, of the phoB gene (data not shown), which is strongly induced when B. subtilis is phosphate-starved. 37) Taken together, these results suggest that cellular sequestration of phosphate by prenyl diphosphate accumulation is unlikely to be the cause of the cytotoxicity observed here.
Another possible explanation is a feedback mechanism, in which cellular prenyl diphosphate concentrations influence overall pathway flux to essential isoprenoids. This is a particularly intriguing possibility, as current understanding of the mechanisms regulating flux through the MEP pathway remains limited. Finally, the molecules might disrupt normal cell functioning due to increased rates of random prenylation of biomolecules, a so-called promiscuous prenylation syndrome. 38) Identifying the mechanistic basis of the observed IPP toxicity is increasingly important as interest continues to grow in utilizing engineered microbial systems to synthesize higher isoprenoids for pharmaceutical and industrial applications.
